Zobrazeno 1 - 10
of 13
pro vyhledávání: '"A. S. Tjulandina"'
Publikováno v:
Тазовая хирургия и онкология, Vol 12, Iss 1, Pp 58-66 (2022)
The aim of the work is to analyze all available literature data on the role of secondary cytoreduction, its effectiveness and safety in the recurrence of ovarian cancer (ОС) with isolated lymph node (LN) lesion.The importance and place of secondary
Externí odkaz:
https://doaj.org/article/9ccef1a0d4554871854d140677c6936f
Autor:
A S Tjulandina
Publikováno v:
Современная онкология, Vol 16, Iss 3, Pp 52-57 (2014)
Treatment of advanced ovarian cancer remains a complex problem, which generates interest in researchers. Since there have been no changes in standard cytostatic treatment for last 20 years, addition of targeted drugs to the first-line therapy is cons
Externí odkaz:
https://doaj.org/article/f555321204024f1795d9d03f2d1e0bc1
Autor:
A. S. Tjulandina, B. E. Polotskii, M. M. Davydov, I. A. Mamichev, T. A. Bogush, V. T. Zarkua, S. A. Kaliuzhny, E. A. Bogush
Publikováno v:
Moscow University Chemistry Bulletin. 72:269-274
In the present research, we compared two datasets obtained from the quantitative estimation of ERCC1 protein using two monoclonal antibodies—8F1 and FL29. Quantitative evaluation of immunofluorescence parameters was performed by flow cytometry on o
Autor:
M. M. Davydov, S. A. Kaliuzhny, E. A. Dudko, T. A. Bogush, A. S. Tjulandina, V. Yu. Kirsanov, E. A. Bogush, Sergei Tjulandin
Publikováno v:
Moscow University Chemistry Bulletin. 71:307-311
Peritoneal dissemination and growth of tumor cells in the ascitic fluid in stages III and IV of recurrent ovarian cancer is difficult to treat; resistance to many anticancer drugs used in the treatment of solid ovarian cancer is observed at this stag
Autor:
A. S. Tjulandina, T. A. Bogush, A. A. Basharina, O. M. Ryabinina, Sergei Tjulandin, E. A. Bogush
Publikováno v:
Doklady. Biochemistry and biophysics. 482(1)
The quantitative immunofluorescence assay of serous ovarian cancer tissue for the expression of estrogen receptors (ERα and ERβ) revealed a higher expression level of ERβ in comparison with ERα in all surgical tumor samples investigated. Signific
Autor:
Sergei Tjulandin, A. S. Tjulandina, E. Bogush, O. Andreeva, A. A. Basharina, I. Mamichev, N. Vikhlyantseva, T. Bogush, A. Scherbakov
Publikováno v:
ESMO Open. 3:A434-A435
Introduction Predictive markers of platinum-based chemotherapy efficacy in patients with ovarian cancer have been widely discussed in recent years. Oestrogen receptors (ER) are involved in regulation of proliferative factors responsible for tumour gr
Autor:
E. A. Dudko, A. S. Tjulandina, E. A. Bogush, T. A. Bogush, Sergei Tjulandin, V. T. Zarkua, Mikhail Davydov, A. V. Semakov
Publikováno v:
Doklady. Biochemistry and biophysics. 457
Autor:
T. Bogush, I. Mamichev, A. S. Tjulandina, O. Rjabinina, N. Vichljantzeva, Mikhail Davydov, S. Kaliuzhny, Sergei Tjulandin, E. Dudko, E. Bogush
Publikováno v:
European Journal of Cancer. 61:S75
Autor:
V. Kirsanov, A. S. Tjulandina, E. Bogush, Sergei Tjulandin, I. Mamichev, O. Rjabinina, S. Kolomiytsev, T. Bogush, E. Dudko
Publikováno v:
European Journal of Cancer. 61:S71
Autor:
E. Dudko, A. N. Grishanina, V. T. Zarkua, Sergei Tjulandin, A. V. Semakov, T. Bogush, A. S. Tjulandina
Publikováno v:
European Journal of Cancer. 50:S129-S130